| 000 | 01407 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516104005.0 | ||
| 264 | 0 | _c20120802 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.2012.8165 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNelson, Lewis S | |
| 245 | 0 | 0 |
_aCurbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS). _h[electronic resource] |
| 260 |
_bJAMA _cAug 2012 |
||
| 300 |
_a457-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadverse effects |
| 650 | 0 | 4 |
_aDrug Overdose _xepidemiology |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aEpidemics |
| 650 | 0 | 4 | _aGovernment Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOff-Label Use |
| 650 | 0 | 4 |
_aOpioid-Related Disorders _xepidemiology |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 |
_aPatient Care _xstandards |
| 650 | 0 | 4 | _aPractice Patterns, Physicians' |
| 650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 |
_aUnited States Food and Drug Administration _xlegislation & jurisprudence |
| 700 | 1 | _aPerrone, Jeanmarie | |
| 773 | 0 |
_tJAMA _gvol. 308 _gno. 5 _gp. 457-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2012.8165 _zAvailable from publisher's website |
| 999 |
_c21990391 _d21990391 |
||